Moderna has purchased a new biomanufacturing facility in Marlborough, Mass., which will be designated for mRNA manufacturing. It is anticipated to open in September 2024, according to an April 28 report from the Worcester Business Journal.
Read the full post on Becker's Hospital Review - Healthcare News
